BLK BlackRock, Inc.
Price Chart
Executive Summary
UBS upgraded BlackRock (BLK) to Buy from Neutral on Feb 23, 2026, part of a six-firm cluster (UBS, Freedom Broker, TD Cowen, BMO Capital, Wells Fargo, Barclays) that recently acted on the stock. UBS maintained its $1,280 price target, implying 20% upside from the current $1,065.60. The firm is a top performer on BLK with an 80% accuracy rate (4 of 5 ratings correct) and an average return of 12.8%. Consensus is overwhelmingly bullish: 19 Buy (83%) and 4 Hold (17%) from 23 analysts, with a mean target of $1,254.13 (17.7% upside). However, earnings estimates are being revised lower — this year's EPS estimate dropped from $54.23 to $53.10 over 30 days, with 12 downgrades vs 3 upgrades. Insider selling is notable: CEO Laurence Fink sold $10.2M in late April, and other executives sold ~$6M combined. While the upgrade aligns with consensus, the downward EPS revisions and heavy insider selling create a mixed picture.
Impact Score
Consensus & Targets
Consensus is heavily bullish: 19 Buy (4 Strong Buy, 15 Buy) and 4 Hold, with 0 Sell ratings from 23 analysts covering BLK. The direction is firmly positive, with 83% of analysts recommending Buy. UBS's upgrade aligns with this consensus, moving from Neutral to Buy.
The mean price target is $1,254.13, median $1,250, high $1,393 (Morgan Stanley), and low $1,140. At $1,065.60, BLK offers 17.7% upside to the mean and 17.3% to the median. UBS's $1,280 target is above both the mean and median, reflecting above-consensus optimism. The current price is 14% below the high target and 6.5% below the low target.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-15 | UBS | maintain | Buy | $1,270.00 |
| 2026-04-15 | Morgan Stanley | maintain | Overweight | $1,393.00 |
| 2026-04-15 | Goldman Sachs | maintain | Buy | $1,313.00 |
| 2026-04-15 | Evercore ISI Group | maintain | Outperform | $1,220.00 |
| 2026-04-15 | Barclays | maintain | Overweight | $1,310.00 |
| 2026-04-15 | Keefe, Bruyette & Woods | maintain | Outperform | $1,240.00 |
| 2026-04-13 | JP Morgan | maintain | Neutral | $1,128.00 |
| 2026-04-10 | Evercore ISI Group | maintain | Outperform | $1,180.00 |
| 2026-04-10 | BMO Capital | maintain | Outperform | $1,200.00 |
| 2026-04-09 | UBS | maintain | Buy | $1,235.00 |
Over the past 30 days, there have been 0 upgrades and 0 downgrades, with 10 maintain actions across firms. However, earnings estimates are being revised down significantly. For the current fiscal year, the EPS estimate fell from $54.23 to $53.10 (down 2.1%) with 12 downgrades vs 3 upgrades. Next year's EPS estimate dropped from $61.84 to $60.66 (down 1.9%) with 13 downgrades vs 2 upgrades. The negative revision trend contrasts with the bullish rating bias.
Firm Track Record — UBS
UBS accuracy: 55% on 5083 calls | avg return: 4.6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 13 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| UBS | 80% | 4/5 | 12.8% | top tier |
| Argus Research | 75% | 3/4 | 12.9% | top tier |
| Wells Fargo | 75% | 6/8 | 6.2% | top tier |
| TD Cowen | 67% | 2/3 | 13.2% | top tier |
| Goldman Sachs | 67% | 2/3 | 4.5% | top tier |
| Barclays | 58% | 7/12 | 5.7% | above average |
| Morgan Stanley | 58% | 7/12 | 5.7% | above average |
| JP Morgan | 57% | 4/7 | 4.9% | above average |
| Citigroup | 50% | 2/4 | 7.9% | below average |
| Deutsche Bank | 50% | 2/4 | 5.9% | below average |
UBS has an 80% accuracy rate on its 5 BLK ratings (4 correct) with an average return of 12.8%, making it a top-tier firm. Other top-tier firms: Argus Research (75% on 4 calls, avg return 12.9%), Wells Fargo (75% on 8 calls, avg return 6.2%). Lowest accuracy: Keefe, Bruyette & Woods (44% on 9 calls, avg return 3.0%). UBS's upgrade carries more weight given its strong record.
Earnings Estimates
Next earnings: Jul 13, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1y | $60.66 | $57.64 — $64.55 | $30.8B | ↑1 ↓0 |
| 0y | $53.10 | $51.97 — $54.14 | $27.9B | ↑0 ↓0 |
| +1q | $13.49 | $12.79 — $13.89 | $7.1B | ↑0 ↓0 |
| 0q | $12.55 | $12.14 — $12.85 | $6.6B | ↑0 ↓0 |
Cross-Platform Signals
Insider trading is heavily bearish: CEO Laurence Fink sold $10.2M on Apr 28, President Robert Kapito sold $3.37M on Apr 27, and other executives sold ~$3M in February. Congressional activity is minimal (1 buy, 1 sell, both small). Institutional data is mixed: Norges Bank initiated a new $2.74B position (bullish) but also exited a prior stake (bearish). Two Sigma added 60% then later trimmed 65.6%, net effect uncertain. No short interest data available. The insider selling diverges from the analyst upgrade, suggesting a cautionary signal.
Actionable Insight
The UBS upgrade reinforces a strong buy consensus, but downward EPS revisions and heavy insider selling create a cautionary backdrop. Wait for earnings on July 13 for confirmation before adding long exposure.
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 31, 2026
9d ago
|
ANALYST-UPGRADE
| $1,070.09 $1,068.15 | ▼ −0.18% | ▼ −0.80% | $994.77 (−7.04%) |
|
May 20, 2026
20d ago
|
Press Release
| $1,061.88 $1,045.38 | ▼ −1.55% | ▼ −3.40% | $994.77 (−6.32%) |
|
May 13, 2026
27d ago
|
13F-HR
| $1,094.06 $1,050.13 | ▼ −4.02% | ▼ −3.88% | $994.77 (−9.08%) |
|
May 13, 2026
28d ago
|
Press Release
| $1,094.06 $1,036.30 | ▼ −5.28% | ▼ −4.12% | $994.77 (−9.08%) |
|
May 1, 2026
5w ago
|
ANALYST-UPGRADE
| $1,070.09 $1,068.15 | ▼ −0.18% | ▼ −0.80% | $994.77 (−7.04%) |
|
Apr 28, 2026
6w ago
|
144
| $1,039.36 $1,073.41 | ▲ +3.28% | ▲ +0.17% | $994.77 (−4.29%) |
|
Apr 27, 2026
6w ago
|
144
| $1,049.28 $1,052.25 | ▲ +0.28% | ▼ −1.41% | $994.77 (−5.19%) |
|
Apr 27, 2026
6w ago
|
Insider Cluster
| $1,053.65 $1,051.98 | ▼ −0.16% | ▼ −0.56% | $994.77 (−5.59%) |
|
Apr 24, 2026
6w ago
|
Press Release
| $1,053.65 $1,051.98 | ▼ −0.16% | ▼ −0.56% | $994.77 (−5.59%) |
|
Apr 20, 2026
7w ago
|
Press Release
| $1,048.41 $1,053.65 | ▲ +0.50% | ▼ −0.41% | $994.77 (−5.12%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access